Funder
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institutes of Health
Reference46 articles.
1. A North American cohort of anti-SAE dermatomyositis: clinical phenotype, testing, and review of cases;Albayda;ACR Open Rheumatol,2021
2. High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody;Allenbach;Brain,2016
3. 224th ENMC International Workshop:: Clinico-sero-pathological classification of immune-mediated necrotizing myopathies Zandvoort, The Netherlands, 14–16 October 2016;Allenbach;Neuromuscul Disord,2018
4. Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities;Allenbach;Autoimmun Rev,2020
5. Inclusion body myositis: series of 30 cases from a Brazilian tertiary center;Alverne;Acta Reumatol Port,2013